BF
CPRX

BOK Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

BOK Financial’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Sell
15,322
-4,263
-22% -$126K 0.01% 568
2026
Q1 		$485K Sell
19,585
-1,808
-8% -$43.1K 0.01% 543
2025
Q4 		$499K Sell
21,393
-113
-0.5% -$2.52K 0.01% 546
2025
Q3 		$424K Sell
21,506
-30
-0.1% -$617 0.01% 597
2025
Q2 		$467K Sell
21,536
-1,049
-5% -$24.8K 0.01% 587
2025
Q1 		$548K Sell
22,585
-1,963
-8% -$44.2K 0.01% 537
2024
Q4 		$538K Sell
24,548
-3,636
-13% -$78.1K 0.01% 544
2024
Q3 		$560K Buy
+28,184
New +$522K 0.01% 542

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BOK Financial's CPRX Position: Q2 2026 in Review

BOK Financial reduced its Catalyst Pharmaceutical (CPRX) stake by 22% in Q2 2026, selling an estimated $126K and leaving 15,322 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #568.

BOK Financial first reported a position in CPRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $560K in Q3 2024. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • BOK Financial held 15,322 shares of Catalyst Pharmaceutical worth $482K as of Q2 2026.
  • BOK Financial sold 4,263 Catalyst Pharmaceutical shares in Q2 2026, an estimated $126K.
  • Catalyst Pharmaceutical made up 0.01% of BOK Financial's portfolio in Q2 2026, its #568 holding.
  • BOK Financial first reported a position in Catalyst Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • BOK Financial's Catalyst Pharmaceutical position peaked at $560K in Q3 2024.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.